Irinotecan hydrochloride
NDC 68083-382, Irinotecan hydrochloride, injection, from Gland Pharma Limited.
- Product NDC
- 68083-382
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212993
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-382 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IRINOTECAN HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-382-01 | 68083038201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-382-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/de634e80-328a-4473-b395-0172683a2411
Use it
Look up 68083-382 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-382 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-382. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.